FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arthur van den Wijngaard

Research Profile

Chemicals & Drugs

Disorders

Physiology

Anatomy

Genes & Molecular Sequences

Procedures

Nucleic Acid Amplification Techniques

Co-author Network

Publications

TOP 3
Chiara Tamiello; Arthur van den Wijngaard; Valerie L R M Verstraeten; Frank P T Baaijens; Jos L V Broers; Miriam A F Kamps; Carlijn C V Bouten
Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations.
Frederik Houben; M A F Kamps; G J J Kierkels; I P C Krapels; C L M Marcelis; F C S Ramaekers; Arthur van den Wijngaard; Valerie L R M Verstraeten; M Coorens; W H De Vos; Jos L V Broers
Cytoplasmic localization of PML particles in laminopathies.
Winnok De Vos; Frederik Houben; Miriam Kamps; Ashraf N Malhas; Erik M M Manders; Carlo L M Marcelis; Frans C S Ramaekers; Arthur van den Wijngaard; Maurice A M van Steensel; David J Vaux; Fons Verheyen; Valerie L R M Verstraeten; Juliën Cox; Jos L V Broers
Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arthur van den Wijngaard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chiara Tamiello; Arthur van den Wijngaard; Valerie L R M Verstraeten; Frank P T Baaijens; Jos L V Broers; Miriam A F Kamps; Carlijn C V Bouten
Soft substrates normalize nuclear morphology and prevent nuclear rupture in fibroblasts from a laminopathy patient with compound heterozygous LMNA mutations.
Nucleus (Austin, Tex.) 2013;4(1):61-73.
2013: Frederik Houben; M A F Kamps; G J J Kierkels; I P C Krapels; C L M Marcelis; F C S Ramaekers; Arthur van den Wijngaard; Valerie L R M Verstraeten; M Coorens; W H De Vos; Jos L V Broers
Cytoplasmic localization of PML particles in laminopathies.
Histochemistry and cell biology 2013;139(1):119-34.
2011: Winnok De Vos; Frederik Houben; Miriam Kamps; Ashraf N Malhas; Erik M M Manders; Carlo L M Marcelis; Frans C S Ramaekers; Arthur van den Wijngaard; Maurice A M van Steensel; David J Vaux; Fons Verheyen; Valerie L R M Verstraeten; Juliën Cox; Jos L V Broers
Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies.
Human molecular genetics 2011;20(21):4175-86.
2009: Valerie L R M Verstraeten; Sandrine Caputo; Maurice A M van Steensel; Isabelle Duband-Goulet; Sophie Zinn-Justin; Miriam Kamps; Helma J H Kuijpers; Cecilia Ostlund; Howard J Worman; Jacob J Briedé; Caroline Le Dour; Carlo L M Marcelis; Michel van Geel; Peter M Steijlen; Arthur van den Wijngaard; Frans C S Ramaekers; Jos L V Broers
The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.
Journal of cellular and molecular medicine 2009;13(5):959-71.
2006: Valerie L R M Verstraeten; Jos L V Broers; Maurice A M van Steensel; Sophie Zinn-Justin; Frans C S Ramaekers; Peter M Steijlen; Miriam Kamps; Helma J H Kuijpers; Diane Merckx; H J M Smeets; Raoul Hennekam; Carlo L M Marcelis; Arthur van den Wijngaard
Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation.
Human molecular genetics 2006;15(16):2509-22.
2006: Rachel I M van Haaften; Blanche Schroen; Ben J A Janssen; Arie van Erk; Jacques J M Debets; H J M Smeets; Jos F M Smits; Arthur van den Wijngaard; Yigal M Pinto; Chris T A Evelo
Biologically relevant effects of mRNA amplification on gene expression profiles.
BMC bioinformatics 2006;7():200.
2005: Encarnación B Gómez García; Ton Ambergen; Marinus J Blok; Arthur van den Wijngaard
Patients with an unclassified genetic variant in the BRCA1 or BRCA2 genes show different clinical features from those with a mutation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2185-90.